fbpx

WHEN & WHERE:

14th October 2015
Universidad Santo Tomás
Santiago, Chile

EVENT

What it's all about

Symposium participants received a comprehensive review of cellular medicine, review current techniques, and learn various applications and protocols for delivering stem cell treatments to patients that address a range of health and aesthetic indications.

The field of regenerative medicine is expanding at an exponential rate. The number of clinical trials employing adult stem cells is now in the thousands.

AGENDA

Event Schedule

Dr. Augusto Brazzini
SURGEON

08:00 - 09:00
STEM CELLS IN THE TREATMENT OF PERIPHERAL VASCULAR DISEASE IN PATIENTS WITH ADVANCED CRITICAL LIMB ISCHEMIA OF LOWER EXTREMITIES:

Patients with Advanced Peripheral Vascular Disease usually related to atherosclerotic disease of the arteries of the lower limbs, especially below knees and feet, where it already exists varying degrees of necrosis, little can be done with the endovascular recanalization or surgical, in the absence of distal vessels that can establish an adequate vascular circulation.

This topic explains how to make the distal movement of the foot, blocked, regenerate, back in patent and to reconnect with the proximal vessels, yet permeable and get a fairly quick and efficient relief of the circulation of the lower limb preventing amputation in 80% of patients. Videos and pictures of the procedure and results are displayed.

Dr. Aldo Parodi
DOCTOR

09:00 - 10:00
Clinical experience in assisted lipotransference with stem cells derived from adipose tissue.

In the history of cosmetic medicine it has been great interest in autologous fat transfer from the beginning of fat grafting in the 1890s The lipoinjerto is a promising treatment, but currently is limited by the unpredictable results a low rate of graft survival due to partial necrosis. In our experience the use of the assistance of autologous stem cells derived from adipose tissue lipoinjection has ensured satisfactory clinical results without major complications, suggesting that ASC supplements are effective and safe. Protocol and clinical cases demonstrate.

Dr. Kipp Van Camp
DOCTOR

10:00 - 11:00
Intravenously Administered Autologous Bone Marrow and Adipose-Derived Stromal cells in the Treatment of Alzheimer’s disease.

We present case study data obtained from four mildly cognitive impaired Alzheimer’s participants who underwent adult harvested stromal vascular fraction treatment at baseline and then every 90 days for a total 180 days. SLUMS cognitive performance test, SPECT, MRI, and CSF protein analysis (including beta-amyloid and total Tau protein) measurements were obtained at baseline, immediately following treatment, and 90 after treatment ended (Day 216).

Improved SLUMS scores were obtained with the first 90 days of the initial treatment. Correspondingly, beta-amyloid and Tau protein were decreased. Improvements were sustained across the group at Day 216.

Rodrigo Arancibia
MsC. MBA

11:00 - 12:00
Quality by design in the process of ex-vivo minimal expansion of adult mesenchymal stem cells for cell therapy.

A growing number of doctors around the world are performing treatments using adult stem cells prepared and administered on the same day of the procedure.

However, the number of purified cells is sometimes insufficient to generate the required therapeutic dose. This is because with increasing age of the patient, the number of viable stem cells decreases.

Furthermore, the tissue type also affects as the concentration of adult stem cells varies, and often the amount of starting tissue is very limited

David Audley
SALES TRAINER, NAVEX Global

11:00 - 12:00
Abstract 1: State of the Cell: Global Trends in Regenerative Medicine. Using data collected from independent survey of stem cells clinics, Audley presents insights into the use of cell as part of the clinical practice of medicine. Working with data collected from the Institute for Global Health and Research, this presentation delves into conditions treated with stem cells, as well as cell types used and how they are processed, and data about average costs of procedures from Latin America to Asia and the Caribbean.

Abstract 2: Effective Patient Acquisition. Using data collected through the development of technologies and over a decade of working in the emerging field of stem cell and regenerative medicine, Audley presents insights into methods of effectively targeted, identifying and engaging qualified patients.

Dr. Enrique Testart
PROFESSOR

13:00 - 14:00
A DETAILED CLINICAL HISTORY AS A PARAMOUNT FACTOR FOR THE INDICATION OF CELLULAR THERAPIES
“We treat patients and not diseases”

Regenerative medicine appears not only as a better alternative solution for patients, but as an obligation to recover the exercise of deep medical consultation to allow fully define the problem and the need of the patient. Regenerative medicine is an incentive to recover the value of anamnesis, clinical interview and observation.

This work became the conceptual basis of an online software, available to users of this area, which is the world’s first MRA specializes in regenerative medicine. My pleasure to introduce STEMDATA, collecting experience and transforms it into a useful tool for doctors working cell therapy and personalized medicine.

Dr. Himanshu Bansal
DOCTOR

14:00 - 15:00
He has used several procedures in an effort to restore some post-injury function, including, as discussed here, stem-cell transplantation and, as reviewed later, omental transposition.In preliminary investigations, Bansal has transplanted bone-marrow-derived stem cells into 11 patients with motor-sensory complete injuries (i.e., ASIA-A) sustained at least a year earlier from contusion or laceration. Nine possessed cervical injuries and two thoracic injuries, and all except one were men.

Although most were younger than 30, age ranged from 20 to 52.
The stem cells were obtained by aspirating ~120 milliliters of bone marrow from the patient’s iliac crest, a bone-marrow abundant area of the pelvis bone, and then obtaining a stem-cell rich concentrate by centrifugation. To maintain their fundamental nature, as well as the presence of regenerative-enhancing growth factors, no further physical, chemical, or biological processing of the cells was carried out before transplantation.

Dr. Rolando Sosa Novelo
DOCTOR

15:00 - 16:00
ELIMINATION OF INTERFERING FIELDS FOR GREATER THERAPEUTIC EFFECT OF STEM CELLS.
The current use of adipose derived Stem Cell and Bone Marrow Stem Cell constitutes a therapeutic approach which day by day gains ground in many medical applications, trough various specialties.

However, for certain conditions we physicians have to adopt other resources in support of therapeutic use of Stem Cells.

Dr. Gilberto Hernandez Falcon
DOCTOR

16:00 - 17:00
AUTOLOGOUS STEM CELL THERAPY COMBINED WITH OZONE IN 12 years old MALE PATIENT with an 8 year old Spinal Cord Injury. SUCCESSFUL EVOLUTION

TOP